Kindora
FuncionalidadesFinanciamiento para Empresas SocialesPreciosDesarrolladores
Acerca deDemos en vivo
Iniciar sesiónRegistrarse
    Kindora
    FuncionalidadesFinanciamiento para Empresas SocialesPreciosDesarrolladores
    Acerca deDemos en vivo
    Iniciar sesiónRegistrarse
    1. Inicio
    2. Fundaciones
    3. Bristol-Myers Squibb Patient Assistance Foundation
    Logo de Bristol-Myers Squibb Patient Assistance Foundation

    Bristol-Myers Squibb Patient Assistance Foundation

    ActivoHuman ServicesFinancia Individuos
    PRINCETON, NJSitio web2125464200

    About Bristol-Myers Squibb Patient Assistance Foundation

    The foundation is overwhelmingly dedicated to providing direct prescription drug assistance to individual patients in need, funding a patient assistance program that covers medication costs for low-income, ill, and infant populations. Nearly all recorded giving is funneled into a single patient-focused program rather than to nonprofit intermediaries or diverse causes, indicating a mission centered on access to medicines for vulnerable individuals.

    Focus Areas

    Direct prescription drug assistance for low-income patientsPatient assistance for serious and chronic illnessesMeans-tested enrollment and financial support for medication access

    Who They Fund

    infantslow-income/needy individualspeople with qualifying illnesses (chronically ill patients)

    Giving Approach

    Extremely concentrated: virtually all funding is directed to a single patient assistance program across a very small number of grants. The foundation makes very large, program-specific disbursements focused on direct-to-patient support rather than diversified or repeat grants to multiple nonprofit organizations.

    About Bristol-Myers Squibb Patient Assistance Foundation

    Bristol-myers Squibb Patient Assistance Foundation Inc directs almost all of its giving to a single purpose: prescription drug assistance for individual patients. The recent record shows three large grants to Individual Patient Programs in Princeton, New Jersey, all labeled for prescription drugs for the care of qualified ill, needy, and infants. That pattern points to a funder built around direct medication support rather than a broad charitable portfolio. The foundation’s active program, the Patient Medicine Assistance Program, provides certain Bristol-Myers Squibb prescription medicines free of charge to eligible patients who need temporary help obtaining listed medicines. The focus is on access to medicines for people facing financial barriers, including low-income patients and individuals with qualifying illnesses. Because the foundation funds individuals, its grantmaking is structured around patient assistance rather than grants to nonprofit intermediaries. Across the latest filings, the foundation’s work is tightly centered on medication access in the United States, with every recorded grant going to a patient-focused program in Princeton.

    What Bristol-Myers Squibb Patient Assistance Foundation Funds

    The foundation’s core work is prescription drug assistance. Its active Patient Medicine Assistance Program provides certain Bristol-Myers Squibb prescription medicines free of charge to eligible patients who need temporary help obtaining listed medicines. That makes medication access, rather than general health programming, the clearest throughline in its grantmaking. Its recent grants also show support for qualified ill, needy, and infant populations through Individual Patient Programs in Princeton, New Jersey. The purpose language consistently ties funding to prescription drugs for care, which places the foundation in direct-service healthcare support. The beneficiary profile is narrow and specific: infants, low-income or needy individuals, and people with qualifying illnesses. The philosophy tags reinforce that pattern with direct service, in-kind support, targeted assistance, and healthcare access support.

    How Bristol-Myers Squibb Patient Assistance Foundation Gives

    The grant-size distribution is extremely large and tightly clustered: p25 is $3,245,667,810, the median is $3,627,470,508, and p75 is $4,009,273,205. That range suggests very high-volume, program-level support rather than many small discretionary awards. The recent record shows repeat funding to the same recipient program across 2023, 2024, and 2025, indicating ongoing support rather than one-off grants. The foundation is a regular funder and funds individuals directly. It also accepts unsolicited requests for its Patient Medicine Assistance Program.

    Financial Snapshot

    Annual Giving

    $2.7B

    Total Assets

    $230.7M

    Total Revenue

    $2.7B

    Total Expenses

    $2.7B

    Typical Grant Size

    Most grants fall between $3.2B and $4B, with a median of $3.6B.

    25th Percentile

    $3.2B

    Median

    $3.6B

    75th Percentile

    $4B

    Geographic Reach

    Local1 state funded
    Intensidad de financiamiento
    Baja
    Alta
    Sede

    Deep Analysis

    Unlock Deep Analysis

    Sign up for a free Kindora account to access AI-generated insights into this funder's giving patterns, decision-makers, and fit signals.

    Get Started Free

    Similar Funders

    See Similar Funders

    Free Kindora accounts unlock side-by-side comparisons with foundations that share this funder's focus areas and giving profile.

    Get Started Free

    Explora guías de subvenciones relacionadas

    Subvenciones de Servicios HumanosSubvenciones de Servicios Humanos en New JerseySubvenciones en New Jersey

    ¿Quieres un Pitch Personalizado para Bristol-Myers Squibb Patient Assistance Foundation?

    Regístrate gratis para ver qué tan bien se adapta tu organización sin fines de lucro a este financiador, obtener un pitch generado por IA y descubrir fundaciones similares.

    Comenzar GratisVer Precios
    Plan gratuito disponible
    Sin contratos
    Boletín Semanal Gratuito

    The Grant Brief

    Inteligencia semanal sobre subvenciones para líderes de impacto social. Oportunidades seleccionadas, tendencias de financiamiento e ideas estratégicas — gratis.

    Únete a más de 500 líderes de impacto social. Cancela tu suscripción cuando quieras. Política de privacidad

    De confianza para equipos con misión social en organizaciones de todo el país

    Logo de Kindora

    Financiadores que puedes encontrar. Financiadores que puedes alcanzar.

    Recibe The Grant Brief — inteligencia semanal sobre subvenciones, gratis

    Enlaces rápidos

    • Funcionalidades
    • Financiamiento para Empresas Sociales
    • Acerca de nosotros
    • De dónde viene nuestra información
    • Historias de éxito
    • Misión
    • Cómo funciona
    • Precios
    • Desarrolladores
    • Presentación de ventas
    • Muro de demanda en vivo
    • Empleos en filantropía
    • Compensación en organizaciones sin fines de lucro
    • Invierte en Kindora
    • Demo en vivo (todos los planes)
    • Demo de prospección individualBeta
    • Blog
    • FAQ
    • Primeros pasos

    Conéctate con nosotros

    LinkedIn

    Buscar Subvenciones

    Subvenciones por CausaSubvenciones por EstadoFundaciones por CiudadSubvenciones para EducaciónSubvenciones para SaludSubvenciones para Artes y CulturaSubvenciones para Medio AmbienteSubvenciones para Desarrollo ComunitarioSubvenciones para Desarrollo Juvenil

    © 2026 Kindora. Todos los derechos reservados.

    Política de privacidadTérminos de servicioEstado del sistema
    EIN (identificación fiscal): 22-3622487Último Formulario 990: 2025Activos totales: 230,7 M US$3 declaraciones registradasEncuentra su declaración 990 completa →
    Descubre si hay afinidad — GratisCuenta gratuita · puntaje de afinidad inmediato · financiadores similares

    Funding Style

    direct servicein-kind support (medication provision)targeted assistancehealthcare access support

    Notable grantees: INDIVIDUAL PATIENT PROGRAMS

    Topics

    prescription drug assistancemedication access programspediatric/infant pharmacological carechronic illness medication managementlow-income patient medication support

    Where Bristol-Myers Squibb Patient Assistance Foundation Makes Grants

    Grantmaking is local and entirely concentrated in the United States. All recorded grants in the recent sample went to Princeton, New Jersey, and New Jersey accounts for 100% of grants in the file. The recipient country distribution shows US: 3 grants. The pattern is therefore geographically narrow, with no recorded non-U.S. recipients.

    Frequently Asked Questions About Bristol-Myers Squibb Patient Assistance Foundation

    What does this foundation fund?

    It funds direct prescription drug assistance for individual patients. The active Patient Medicine Assistance Program provides certain Bristol-Myers Squibb prescription medicines free of charge to eligible patients who need temporary help obtaining listed medicines.

    Who receives support?

    The foundation’s grants are aimed at individual patients, including qualified ill, needy, and infant populations. The beneficiary profile also includes low-income or needy individuals and people with qualifying illnesses.

    How large are the grants?

    The grant-size distribution is very large: p25 is $3,245,667,810, the median is $3,627,470,508, and p75 is $4,009,273,205. The recent filings show repeated multibillion-dollar program support.

    Does it accept unsolicited requests?

    Yes. The active Patient Medicine Assistance Program is listed as accepting unsolicited requests, and it is focused on helping eligible patients obtain listed medicines temporarily.

    Where does the foundation give?

    Its giving is local and concentrated in the United States. In the recent grant sample, all recorded grants went to Princeton, New Jersey, and New Jersey accounts for 100% of grants in the file.

    Cancela cuando quieras
    Latest 990 Filing

    2025

    Source: IRS Form 990-PF, fiscal year 2025.

    Recent Grants

    Most recent grants reported to the IRS.

    RecipientLocationAmountYearPurpose
    INDIVIDUAL PATIENT PROGRAMSPRINCETON, NJ$2,658,494,8662025PRESCRIPTION DRUGS FOR CARE OF QUALIFIED ILL, NEEDY, AND INFANTS
    INDIVIDUAL PATIENT PROGRAMSPRINCETON, NJ$4,391,075,9032024PRESCRIPTION DRUGS FOR CARE OF QUALIFIED ILL, NEEDY, AND INFANTS
    INDIVIDUAL PATIENT PROGRAMSPRINCETON, NJ$2,863,865,1122023PRESCRIPTION DRUGS FOR CARE OF QUALIFIED ILL, NEEDY, AND INFANTS

    INDIVIDUAL PATIENT PROGRAMS

    $2,658,494,866
    PRINCETON, NJ2025

    PRESCRIPTION DRUGS FOR CARE OF QUALIFIED ILL, NEEDY, AND INFANTS

    INDIVIDUAL PATIENT PROGRAMS

    $4,391,075,903
    PRINCETON, NJ2024

    PRESCRIPTION DRUGS FOR CARE OF QUALIFIED ILL, NEEDY, AND INFANTS

    INDIVIDUAL PATIENT PROGRAMS

    $2,863,865,112
    PRINCETON, NJ2023

    PRESCRIPTION DRUGS FOR CARE OF QUALIFIED ILL, NEEDY, AND INFANTS